[What are the effectiveness and safety of post-renal transplantation pharmacological therapy for bone disease?]
- PMID: 18457560
[What are the effectiveness and safety of post-renal transplantation pharmacological therapy for bone disease?]
Comment on
-
Interventions for preventing bone disease in kidney transplant recipients.Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005015. doi: 10.1002/14651858.CD005015.pub3. Cochrane Database Syst Rev. 2007. PMID: 17636784 Review.
Similar articles
-
Selection of antiresorptive or anabolic treatments for postmenopausal osteoporosis.Nat Clin Pract Endocrinol Metab. 2008 Sep;4(9):514-23. doi: 10.1038/ncpendmet0941. Nat Clin Pract Endocrinol Metab. 2008. PMID: 18714329 Review.
-
A 6-month, multicenter, single-arm pilot study to evaluate the efficacy and safety of generic tacrolimus (TacroBell) after primary renal transplantation.Transplant Proc. 2009 Jun;41(5):1671-4. doi: 10.1016/j.transproceed.2009.03.061. Transplant Proc. 2009. PMID: 19545705
-
Review article: Managing bone complications after kidney transplantation.Nephrology (Carlton). 2009 Jun;14(4):437-42. doi: 10.1111/j.1440-1797.2009.01156.x. Nephrology (Carlton). 2009. PMID: 19563386 Review.
-
Evaluation and management of bone disease and fractures post transplant.Transplant Rev (Orlando). 2008 Jan;22(1):52-61. doi: 10.1016/j.trre.2007.09.001. Transplant Rev (Orlando). 2008. PMID: 18631858 Review.
-
Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.Liver Transpl. 2009 May;15(5):504-8. doi: 10.1002/lt.21710. Liver Transpl. 2009. PMID: 19399742
Publication types
LinkOut - more resources
Full Text Sources